Ibritumomab Intravenous and Prochlorperazine Edisylate
Determining the interaction of Ibritumomab Intravenous and Prochlorperazine Edisylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: prochlorperazine
Brand name: Compazine, Compro
Synonyms: Prochlorperazine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Prochlorperazine Injection
- Ibritumomab Intravenous-Prochlorperazine Maleate
- Ibritumomab Intravenous-Prochlorperazine rectal
- Ibritumomab Intravenous-Prochlorperazine Suppositories
- Ibritumomab Intravenous-Prochlorperazine Suppository
- Ibritumomab Intravenous-Prochlorperazine Tablets
- Prochlorperazine Edisylate-Ibritumomab Tiuxetan
- Prochlorperazine Edisylate-Ibrutinib
- Prochlorperazine Edisylate-Ibrutinib Capsules
- Prochlorperazine Edisylate-Ibrutinib Tablets
- Prochlorperazine Edisylate-Ibu
- Prochlorperazine Edisylate-IBU Tablets